Viewing nowLyrica CR Extended-Release Tablets 330 mg (Pregabalin)
Pregabalin 330mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

MFDS item code 201802991 · Approved 2018.07.18 · Insurance code 073400270
Relief of peripheral neuropathic pain
This medication is used to treat pain caused by peripheral neuropathy in adult patients. Peripheral neuropathic pain mainly appears in various forms, such as numbness, tingling, and burning sensations in the hands and feet, and this medication helps to alleviate these symptoms and improve the quality of life for patients. It helps control pain due to nerve damage, reducing discomfort and aiding comfort.
This medication should be taken once daily after the evening meal. It should be swallowed whole and not split, crushed, or chewed. A starting dose of 165 mg once daily may be taken, and after 3 to 7 days, the dose may be increased to 330 mg once daily. If necessary, the dose may be further increased to a maximum of 660 mg once daily at 7-day intervals. Patients with reduced kidney function should have their doses adjusted based on creatinine clearance.
Safety and efficacy data is insufficient for children under 12 years old and adolescents aged 12-17 years, so administration is not recommended.
This medication may increase the risk of suicidal thoughts or behaviors, so it is important to carefully monitor mood changes or symptoms of depression during treatment. Those allergic to pregabalin or any of its components should not take this medication. Diabetic patients may be affected by weight gain in terms of blood sugar control, so dose adjustments for diabetes medications may be necessary. If serious allergic reactions occur, such as angioedema, treatment should be discontinued immediately and healthcare professionals should be notified. Elderly patients may experience increased dizziness or drowsiness, posing a risk of falls, so caution is especially necessary at the beginning of treatment. Some patients may experience blurred vision or changes in vision; if these symptoms occur, consult a physician. When discontinuing this medication, withdrawal symptoms such as insomnia, headache, or anxiety may occur, so sudden cessation should be avoided. Patients with a history of drug abuse may be at higher risk for abusing this medication, and caution is needed during use. Patients with decreased kidney function require dose adjustments, and it is not recommended for dialysis patients. Patients with heart disease should use this medication cautiously due to risks such as congestive heart failure. This medication has central nervous system depressant effects, and caution is needed when taken with opioids or other drugs that may increase the risk of respiratory depression. During early pregnancy, there may be a risk of congenital abnormalities in the fetus, so pregnant women are advised not to take it, and women of childbearing age should use effective contraception. It is recommended that breastfeeding women discontinue breastfeeding or the medication itself, as the drug can be passed through breast milk. Engaging in activities such as driving or operating machinery may pose an accident risk due to dizziness or drowsiness, so these activities should be avoided if such symptoms occur after taking the medication. In the event of an overdose, symptoms such as confusion, drowsiness, or seizures may occur, so immediate medical attention is required. This medication should be stored out of reach of children, and transferring to other containers should be avoided.
Severe swelling (angioedema, facial swelling, swelling around the mouth and upper respiratory tract), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral and ocular mucosa, severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis), respiratory issues (breathing difficulty, pulmonary edema, severe respiratory depression), jaundice (yellowing of skin or eyes), liver abnormalities, sudden and severe
Dizziness, drowsiness, nausea, dry mouth, constipation, diarrhea, vomiting, fatigue, headache, blurred vision, diplopia, vertigo, increased appetite, joint pain, back pain, erectile dysfunction, cough, skin rash, contact dermatitis, sweating, papular rash, hives, tremors, insomnia, anxiety, depression, suicidal thoughts, hyperhidrosis, increased serum alanine aminotransferase (ALT), increased aspartate aminotransferase (AST), increased blood sugar,
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is best to keep it at room temperature between 1 degree and 30 degrees Celsius.
Pink almond-shaped film-coated extended-release tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 330mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.